These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2556225

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation.
    Gantner F, Götz C, Gekeler V, Schudt C, Wendel A, Hatzelmann A.
    Br J Pharmacol; 1998 Mar; 123(6):1031-8. PubMed ID: 9559883
    [Abstract] [Full Text] [Related]

  • 26. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study.
    Gantner F, Tenor H, Gekeler V, Schudt C, Wendel A, Hatzelmann A.
    J Allergy Clin Immunol; 1997 Oct; 100(4):527-35. PubMed ID: 9338548
    [Abstract] [Full Text] [Related]

  • 27. Elevated leukocyte phosphodiesterase as a basis for depressed cyclic adenosine monophosphate responses in the Basenji greyhound dog model of asthma.
    Chan SC, Hanifin JM, Holden CA, Thompson WJ, Hirshman CA.
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 1):148-58. PubMed ID: 2991358
    [Abstract] [Full Text] [Related]

  • 28. Synergistic effects of interleukin 4 and interferon-gamma on monocyte phosphodiesterase activity.
    Li SH, Chan SC, Toshitani A, Leung DY, Hanifin JM.
    J Invest Dermatol; 1992 Jul; 99(1):65-70. PubMed ID: 1318907
    [Abstract] [Full Text] [Related]

  • 29. Adenylate cyclase activity in mononuclear leucocytes from patients with atopic dermatitis.
    Holden CA, Chan SC, Hanifin JM.
    Acta Derm Venereol Suppl (Stockh); 1985 Jul; 114():149-51. PubMed ID: 2988251
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Heterologous desensitization of leukocytes: a possible mechanism of beta adrenergic blockade in atopic dermatitis.
    Safko MJ, Chan SC, Cooper KD, Hanifin JM.
    J Allergy Clin Immunol; 1981 Sep; 68(3):218-25. PubMed ID: 6114971
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition.
    Chan SC, Li SH, Hanifin JM.
    J Invest Dermatol; 1993 May; 100(5):681-4. PubMed ID: 8388009
    [Abstract] [Full Text] [Related]

  • 35. Atopic dermatitis: skin care and topical therapies.
    Fleischer DM, Udkoff J, Borok J, Friedman A, Nicol N, Bienstock J, Lio P, Tollefson MM, Eichenfield LF.
    Semin Cutan Med Surg; 2017 Sep; 36(3):104-110. PubMed ID: 28895956
    [Abstract] [Full Text] [Related]

  • 36. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity.
    Sampson HA, Broadbent KR, Bernhisel-Broadbent J.
    N Engl J Med; 1989 Jul 27; 321(4):228-32. PubMed ID: 2473400
    [Abstract] [Full Text] [Related]

  • 37. Preliminary identification and role of phosphodiesterase isozymes in human basophils.
    Peachell PT, Undem BJ, Schleimer RP, MacGlashan DW, Lichtenstein LM, Cieslinski LB, Torphy TJ.
    J Immunol; 1992 Apr 15; 148(8):2503-10. PubMed ID: 1373172
    [Abstract] [Full Text] [Related]

  • 38. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis.
    Hanifin JM, Chan SC, Cheng JB, Tofte SJ, Henderson WR, Kirby DS, Weiner ES.
    J Invest Dermatol; 1996 Jul 15; 107(1):51-6. PubMed ID: 8752839
    [Abstract] [Full Text] [Related]

  • 39. Atopic dermatitis: a defect of intracellular secondary messenger systems?
    Holden CA.
    Clin Exp Allergy; 1990 Mar 15; 20(2):131-6. PubMed ID: 2162724
    [Abstract] [Full Text] [Related]

  • 40. Basic and clinical aspects of atopic dermatitis.
    Hanifin JM.
    Ann Allergy; 1984 Jun 15; 52(6):386-95. PubMed ID: 6145376
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.